BHST vs SLSN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BHST shows bearish fundamentals based on deterministic rules. Financial strength is weak (F-Score 1/9). Concerns include weak profitability or high valuation.
SLSN exhibits a stable Piotroski F-Score of 5/9, but this is overshadowed by severe valuation misalignment and negative growth. The stock is trading at $1.25, which is a massive premium compared to its Graham Number ($0.34) and Intrinsic Value ($0.14). With negative YoY revenue growth (-0.70%) and a catastrophic -50% decline in EPS growth, the current price is unsupported by fundamentals. The recent 1-month price bounce appears speculative given the 0/4 earnings beat record over the last year.
Compare Another Pair
Related Comparisons
BHST vs SLSN: Head-to-Head Comparison
This page compares BioHarvest Sciences Inc. (BHST) and Solesence, Inc. (SLSN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.